ARTV
Artiva Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.18
-0.57 ▼ -8.44%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$5.99
-0.19 ▼ -3.07%
| Index | - | P/E | - | EPS (ttm) | -3.43 | Insider Own | 49.95% | Shs Outstand | 0.02B | Perf Week | 7.67% |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | 17.09% | Insider Trans | -0.28% | Shs Float | 0.01B | Perf Month | 60.52% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | -0.87 | Inst Own | 48.74% | Short Float | 1.2% | Perf Quarter | 101.3% |
| Income | -0.08B | P/S | - | EPS this Y | 1.6% | Inst Trans | -7.48% | Short Ratio | 0.14 | Perf Half Y | 132.33% |
| Sales | 0.00B | P/B | 1.38 | EPS next 5Y | 11.12% | ROA | -48.74% | Short Interest | 0.15M | Perf YTD | 44.06% |
| Book/sh | 4.47 | P/C | 1.41 | EPS past 3/5Y | -12.33% -27.38% | ROE | -56.55% | 52W High | -20.3% ($7.75) | Perf Year | 10.36% |
| Cash/sh | 4.37 | P/FCF | - | Sales past 3/5Y | - | ROIC | -71.16% | 52W Low | 320.41% ($1.47) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -16.59% | Gross Margin | - | Volatility(W/M) | 14.46% 10.57% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.61 | EPS Q/Q | -27.57% | Profit Margin | - | RSI (14) | 61.59 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.61 | Sales Q/Q | - | SMA20 | 14.85% ($5.38) | Beta | 1.64 | Target Price | $17 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 3000000 | SMA50 | 29.43% ($4.77) | Rel Volume | 0.19 | Prev Close | $6.75 |
| Employees | 104 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | -0.37% - | SMA200 | 79.16% ($3.45) | Avg Volume(3M) | 1.06M | Price | $6.18 |
| IPO | 2024/7/19 | Option/Short | No/Yes | Trades | 1384 | Volume | 203,629 | Change | -8.44% |
뉴스 로딩 중...